Survival period doubled! AstraZeneca's new gastric cancer drug Sone-ve targets annual sales of $5 billions, further advancing ADC's replacement of chemotherapy.
智通财经2026/10/26 01:36Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Zhitao Finance APP, AstraZeneca’s (AZN.US) investigational gastric cancer drug doubled patient survival in a late-stage trial, adding to the prospects of another potential blockbuster therapy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$80,027.61
-0.72%
Ethereum
ETH
$2,318.74
-1.20%
Tether USDt
USDT
$0.9986
-0.01%
BNB
BNB
$738.17
-0.82%
XRP
XRP
$1.28
-1.80%
USDC
USDC
$0.9998
-0.01%
Solana
SOL
$100.56
-1.14%
TRON
TRX
$0.3298
+0.34%
Zcash
ZEC
$1,201.25
+0.28%
Hyperliquid
HYPE
$75.96
-0.12%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now